BKGI.BK Bangkok Genomics Innovation Pcl

Healthcare Diagnostics & Research Thailand Exchange
2.30 THB
Close of Nov 7, 2026
1.16 2.58
Market cap
THB 1.38B
P/E
14.4x
P/B
2.36x
ROE
21.3%
Dividend yield
2.03%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is BKGI.BK undervalued?

Graham number
Price2.30
Graham value1.87
Premium22.9%

BKGI.BK trades 22.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bangkok Genomics Innovation Pcl fundamental analysis

No fundamental analysis for Bangkok Genomics Innovation Pcl yet.

Bangkok Genomics Innovation Pcl stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bangkok Genomics Innovation Pcl

Bangkok Genomics Innovation Public Company Limited provides medical analysis services in Thailand. The company offers screening for fetal chromosomal abnormalities using non-invasive prenatal testing under the NIFTY brand, preimplantation chromosomal abnormality and thalassemia carrier gene screening, infectious disease group analysis, and monkeypox virus analysis. It also provides other screening tests, such as cancer-related gene screening to predict the risk of inherited …

Full company profile